Compare IDN & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDN | SRTS |
|---|---|---|
| Founded | 1994 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 45.6M |
| IPO Year | 2014 | 2016 |
| Metric | IDN | SRTS |
|---|---|---|
| Price | $2.42 | $2.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $4.83 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 142.9K | 17.6K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | $4,433,454.00 | ★ $27,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $41.11 |
| P/E Ratio | $39.92 | ★ N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $2.12 | $2.66 |
| 52 Week High | $9.08 | $5.49 |
| Indicator | IDN | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 54.76 | 52.81 |
| Support Level | $2.19 | $2.97 |
| Resistance Level | $2.46 | $3.17 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 76.83 | 76.47 |
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.